Clinical and Echocardiographic Predictors of Outcomes in Patients With Moderate (Mean Transvalvular Gradient 20 to 40 mm Hg) Aortic Stenosis.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 12 2019
Historique:
received: 29 06 2019
revised: 07 09 2019
accepted: 10 09 2019
pubmed: 5 11 2019
medline: 2 4 2020
entrez: 5 11 2019
Statut: ppublish

Résumé

Risk factors for adverse clinical outcomes in patients with moderate aortic stenosis are not well defined. Previous studies have suggested that certain patients with moderate AS may be at an increased risk of heart failure (HF) or death. All patients with moderate AS seen in our institution during the study period (6/1/2014 to 6/30/2017) with a minimum 1-year follow-up were included. Clinical and echocardiographic data were collected retrospectively. End points were defined as HF hospitalization, aortic valve replacement (AVR), or death. Kaplan-Meier and multivariable Cox proportional hazard models analyses were conducted using composite outcomes of (1) HF hospitalization or AVR and (2) HF hospitalization, AVR, or all-cause death. A total of 151 subjects met the inclusion criteria. The most significant risk factors associated with the composite outcomes were an ejection fraction (EF) <50% ((1) hazard ratio [HR]: 4.1; 95% confidence interval [CI]: 2.34, 7.12; (2) HR: 3.8; 95% CI: 2.2, 6.6), atrial fibrillation ((1) HR: 2.0; 95% CI: 1.2, 3.2; (2) HR: 2.1; 95% CI: 1.43, 3.2), left ventricular hypertrophy ((1) HR: 5.85; 95% CI: 2.0, 15.8; (2) HR: 3.2; 95% CI: 1.4, 7.4), aortic valve area ((1) HR: 0.3; 95% CI: 0.1, 0.6; (2) HR: 0.32; 95% CI: 0.1, 0.65), and abnormal right ventricular function ((1) HR: 4.3; 95% CI: 2.5, 7.5; (2) HR: 5.5; 95% CI: 3.0, 9.8). In conclusion, presence of reduced ejection fraction, atrial fibrillation, left ventricular hypertrophy, and abnormal right ventricular function are associated with an increased risk of HF hospitalization, AVR, and death in patients with moderate aortic stenosis.

Identifiants

pubmed: 31679642
pii: S0002-9149(19)31061-6
doi: 10.1016/j.amjcard.2019.09.022
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1924-1931

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Katie R Murphy (KR)

School of Medicine, Oregon Health & Science University, Portland, Oregon.

Omar A Khan (OA)

School of Medicine, Oregon Health & Science University, Portland, Oregon.

Allen C Rassa (AC)

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.

Miriam R Elman (MR)

School of Public Health, Portland State University-Oregon Health & Science University, Portland, Oregon.

Scott M Chadderdon (SM)

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.

Howard K Song (HK)

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; Division of Cardiothoracic Surgery, Oregon Health & Science University, Portland, Oregon.

Harsh Golwala (H)

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.

Joaquin E Cigarroa (JE)

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.

Firas E Zahr (FE)

Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: zahr@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH